Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Hexaglim-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Hicxica Formulations Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Hexaglim-M 1 Tablet SR

GlucoDuo-SR, a single-strength tablet, is classified as an antidiabetic medication. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. GlucoDuo-SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled glucose levels, as abrupt cessation can lead to hyperglycemia, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management, as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are vital to mitigate this risk. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain is also possible. This medicine is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose checks, along with potential blood tests for complete blood count and liver function, will be recommended by your doctor.

Uses of Hexaglim-M 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Hexaglim-M 1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Hexaglim-M SR tablet with a meal.

Common Side effects of Hexaglim-M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Hexaglim-M 1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take one Hexaglim-M 1 SR tablet with a meal.

How Hexaglim-M 1 Tablet SR works:

Hexaglim-M SR, a single-tablet formulation, combines glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts through three mechanisms: decreased hepatic glucose production, reduced intestinal glucose absorption, and enhanced insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Hexaglim-M 1 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Hexaglim-M 1 mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Use of the extended-release Hexaglim-M tablet during lactation is contraindicated. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Hexaglim-M 1 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For individuals with severe kidney disease, Hexaglim-M 1 Tablet SR is contraindicated. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

For individuals with liver impairment, the extended-release Hexaglim-M 1 mg tablet requires careful administration. Dosage modification may be necessary. Physician consultation is advised. Initiation with a low dose is typical for patients exhibiting mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Hexaglim-M 1 Tablet SR :

Should you forget to take a Hexaglim-M 1 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Hexaglim-M 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Hexaglim-M 1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Hexaglim-M 1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Hexaglim-M 1 Tablet SR and seek immediate medical attention.
Hexaglim-M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Hexaglim-M 1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Hexaglim-M 1 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually, as suggested by some researchers.
Hexaglim-M 1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Hexaglim-M 1 Tablet SR with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Hexaglim-M 1 Tablet SR
86
MRP 105
18% off